Name | 3-[(2-benzyl-3-sulfanylpropanoyl)amino]propanoic acid |
---|---|
Synonyms |
sq 28,603
SQ28603 |
Description | SQ28603 is a potent and selective inhibitor of neutral endopeptidase 3.4.24.11 (NEP), an enzyme that degrades atrial natriuretic peptide (ANP). |
---|---|
Related Catalog | |
Target |
NEP[1] |
In Vivo | In conscious deoxycorticosterone acetate (DOCA)/salt hypertensive rats, 300 μmol/kg, i.v., of SQ28603 significantly lowers mean arterial pressure (MAP) from 177±12 to 154±8 mm Hg and increases urinary cyclic guanosine monophosphate (GMP) excretion from 204±70 to 1,068±326 pmol/kg/min within 2 h. SQ28603 also significantly reduces NEP activity by 95% in the kidneys (1.28±0.08 vs. 18.35±0.61 μmol/min after SQ28603 and vehicle respectively) and by 77% in the lungs (0.29±0.03 vs. 0.92±0.14 μmol/kg after SQ28603 and vehicle, respectively). In conclusion, inhibition of NEP activity by SQ28603 significantly decreases MAP and increases plasma ANP concentrations and urinary excretion of cyclic GMP in conscious DOCA/salt hypertensive rats[1]. The potent neutral endopeptidase inhibitor SQ28603 significantly increases excretion of sodium from 4.9±2.3 to 14.3±2.1 muequiv./min and cyclic 3',5'-guanosine monophosphate from 118±13 to 179±18 pmol/min after intravenous administration of 300 μmol/kg (approximately 80 mg/kg) in conscious female cynomolgus monkeys[2]. |
References |
Density | 1.216g/cm3 |
---|---|
Boiling Point | 533.3ºC at 760mmHg |
Molecular Formula | C13H17NO3S |
Molecular Weight | 267.34400 |
Flash Point | 276.3ºC |
Exact Mass | 267.09300 |
PSA | 108.69000 |
LogP | 2.20630 |
Vapour Pressure | 3.34E-12mmHg at 25°C |
Index of Refraction | 1.569 |
Storage condition | 2-8℃ |